MedTrace Logo

CPAP, Nutrition & Exercise Against Sleep Apnea

NCT03959280 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-08-09

No results posted yet for this study

Summary

This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.

Conditions

Interventions

OTHER

Tailored intervention

* The exercise program consists of 2 x 1.5-hour supervised nordic walking sessions weekly during 12 weeks and 1-hour unsupervised moderate physical activity per week from week 4. * The diet intervention includes one face-to-face consultation with a dietician and one telephone-based contact monthly, i.e. 6 diet interventions for 12 weeks. * Behavioural changes techniques will be included in diet and exercise interventions.

OTHER

Control

This intervention will include tailored instruction on CPAP use and standard advices on physical activity and nutrition at CPAP initiation.

Sponsors & Collaborators

  • Swiss Lung Association

    collaborator UNKNOWN

  • Ligue Pulmonaire Vaudoise

    collaborator UNKNOWN

  • Raphael Heinzer

    lead OTHER

Principal Investigators

  • Raphael Heinzer, MD, PhD · University Hospital of Lausanne, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-21
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03959280 on ClinicalTrials.gov